SEC Form 4 · accession 0001001250-15-000069

ESTEE LAUDER COMPANIES INC · EL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, Clinique Labs LLC · 10% Owner

Period of report

Aug 27, 2015

Accepted (ET)

Aug 31, 2015 · 2:37 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001001250

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Common Stock^F2	Aug 27, 2015	C	35,000	—	A	35,000	D
Class A Common Stock^F3	Aug 27, 2015	G	25,000	—	D	10,000	D
Class A Common Stock^F3	Aug 27, 2015	G	10,000	—	D	0	D
Class A Common Stock^F4	holding	—	—		—	6,364	I	by Descendants of RSL 1966 Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F3,F2	—	Aug 27, 2015	C	35,000	D	—	—	Class A Common Stock	35,000	10,012,031	D
Class B Common Stock^F4,F2	—	holding	—	—	—	—	—	Class A Common Stock	6,364	6,364	I

F1Ronald S. Lauder ("RSL") converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
F2There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
F3Not applicable.
F4RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.